CD4 and neoplasm: Functional assays confirmed that miR‐19a‐3p enhances CD4+ T cell cytotoxicity and counteracts HBx‐driven lymphomagenesis, establishing a mechanistic connection between viral regulation and anti‐tumour immunity.